The identification of different BRCA1-associated ovarian cancer subtypes, such as high-grade serous ovarian cancer, further emphasizes the importance of understanding the genetic landscape to develop targeted therapeutic approaches. The gene discussed is BRCA1; the disease is ovarian carcinoma.